Severe pneumonia caused by 2009 pandemic influenza A (H1N1) virus in children and corticosteroid treatment

Korean Journal of Pediatric Infectious Diseases

Volumn 18, Issue 2, 2011, Pages 193-200

  Sohn, Yu Rak ^a   Kim, Jong Hee ^a   Ma, Sang Hyuk ^b   Lee, Kyung Yil ^c   Kang, Jin Han ^c  

^a Fatima Hospital   (South Korea)

^b Changwon Fatima Hospital   (South Korea)

^c The Catholic University of Korea   (South Korea)

Author keywords

Children; Corticosteroid; H1N1 influenza virus; Pneumonia

Indexed keywords

METHYLPREDNISOLONE; OSELTAMIVIR;

2009 H1N1 INFLUENZA; ABSENCE OF SIDE EFFECTS; ARTICLE; CHILD; CLINICAL ARTICLE; CORTICOSTEROID THERAPY; DISEASE SEVERITY; DYSPNEA; FEMALE; FEVER; GROUPS BY AGE; HUMAN; LUNG INFILTRATE; MALE; MEDICAL RECORD REVIEW; OXYGEN THERAPY; PNEUMONIA; PRESCHOOL CHILD; RESPIRATORY DISTRESS; SCHOOL CHILD;

EID: 84869119027     PISSN: 12263923     EISSN: None     Source Type: Journal    
DOI: 10.14776/kjpid.2011.18.2.193     Document Type: Article

References (33)

1. Neumann G, Noda T, Kawaoka Y. Emergence and pandemic potential of swine-origin H1N1 influenza virus. Nature 2009;459:931-9.
2. Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 2009;360: 2605-15.
3. World Health Organization [homepage on the Internet]. Geneva, Switzerland: WHO c2009 [updated 2009 June 11 cited 2009 July 17]. Global Alert and Response; [about 2 screens]. Available from: http://www.who.int/csr/diseea/ swineflu/frequently-asked-questions/levels-pandemic-alert/en/index.html
4. Kim WJ. Novel influenza A/H1N1 pandemic: current status and prospects J Korean Med Assoc 2009;52:787-94.
5. Korean Center for Disease Control. Epidemiology of early detected Novel InfluenzaA(H1N1) in Korea, 2009. Public Health Wkly Rep 2009;2:689-91.
6. Lee HJ, Min SJ, Choi JW, Kang EK. Clinical characteristics of hospitalized pediatric patients with 2009 novel influenza A infection. Pediatr Allergy Respir Dis 2010; 30:130-7.
7. Writing Committee of the WHO Consultationon Clinical Aspects of Pandemic (H1N1) 2009 Influenza, Bautista E, Chotpitayasunondh T, Gao Z, Harper SA, Shaw M, Uyeki TM, et al. Clinical aspects of pandemic 2009 influenza A(H1N1) virus infection. N Engl J Med 2010; 362:1708-19.
8. Falagas ME, Vouloumanou EK, Baskouta E, Rafailidis PI, Polyzos K, Rello J. Treatment options for 2009 H1N1 influenza: evaluation of the published evidence. Intern J Antimicrob Agents 2010;35:421-30.
9. Reddy D. Responding to pandemic (H1N1) 2009 influenza: the role of oseltamivir. J Antimicrob Chemother 2010 Apr;65(Suppl 2):ii35-ii40.
10. de Jong MD, Simmons CP, Thanh TT, Hien VH, Smith GJ, Chau TN, et al. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat Med 2006;12:1203-7. (Pubitemid 44527358)
11. Eichelberger MC. The cotton rat as a model to study influenza pathogenesis and immunity. Viral Immunol 2007;20:243-9. (Pubitemid 47076206)
12. La Gruta NL, Kedzierska K, Stambas J, Doherty PC. A question of self-reservation: immunopathology in influenza virus infection. Immunol Cell Biology 2007;85: 85-92. (Pubitemid 46398724)
13. To KK, Hung IF, Li IW, Lee KL, Koo CK, Yan WW, et al. Delayed clearance of viral load and marked cytokine activation in severe cases of pandemic H1N1 2009 influenza virus infection. Clin Infect Dis 2010;50:850-9.
14. Lee KY, Rhim JW, Kang JH. Hyperimmune cells(Tcells) mayberesponsible for acute lung injury in influenza virus infections: aneed for early immune-modulators for severe cases. Med Hypotheses 2011;76:64-9.
15. Quispe-Laime AM, Bracco JD, Barberio PA, Campagne CG, Rolfo VE, Umberger R, et al. H1N1 influenza A virus-associated acute lung injury: response to combination oseltamivir and prolonged corticosteroid treatment. Intensive Care Med 2010;36:33-41.
16. Linko R, Pettila V, Ruokonen E, Varpula T, Sari Karlsson S, Tenhunen J, et al. FINN H1N1-study group. Corticosteroid therapy in intensive care unit patients with PCR-confirmed influenza A(H1N1) infection in Finland. Acta Anesth Scand (In press).
17. Confalonieri M, Cifaldi R, Dreas L, Viviani M, Biolo M, Gabrielli M. Methylprednisolone infusion for life-threatening H1N1-virus infection. Ther Adv Respir Dis 2010;4:233-7.
18. Roberts C, Nirmalan M, O'Shea S. Steroid-sensitive post-viral inflammatory pneumonitis (PVIP). AmJ Respir Crit Care Med 2010;182:1089-90.
19. Kil HR, Lee JH, Lee KY, Rhim JW, Youn YS, Kang JH. Early corticosteroid treatment for severe pneumonia caused by 2009 H1N1 influenza virus. Critical Care 2011;15:413.
20. Annane D. Pro: The illegitimate crusade against corticosteroids for severe H1N1 pneumonia. Am J Respir Crit Care Med 2011;183:1125-6.
21. Rhim JW, Lee KY, Youn YS, Kang JH, Kim JC. Epidemiological and clinical characteristics of childhood pandemic 2009 H1N1 virus infection: An observational cohort study. BMC infect Dis 2011;11:225.
22. Bettinger JA, Sauvé LJ, Scheifele DW, Moore D, Vaudry W, Tran D, et al. Pandemic influenza in Canadian children: a summary of hospitalized pediatric cases. Vaccine 2010;28:3180-4.
23. Matthay MA, Lia KD. Con: Corticosteroids are not indicated for treatment of acute lung injury from H1N1 viral pneumonia. Am J Respir Crit Care Med 2011;183: 1127-8.
24. Kim SH, Hong SB, Yun SC, Choi WI, Ahn JJ, Lee YJ. Corticosteroid treatment in critically ill patients with pandemic influenza A/H1N1 2009 infection: analytic strategy using propensity scores. Am J Respir Crit Care Med 2011;183:1207-14.
25. Brun-Buisson C, Richard JC, Mercat A, Thiébaut A, Brochard L. Early corticosteroids in severe Influenza A/ H1N1 pneumonia and acute respiratory distress syndrome. Am J Respir Crit Care Med 2011;183:1200-6.
26. Witkop CT, Duffy MR, Macias EA, Gibbons TF, Escobar JD, Burwell KN, et al. Novel influenza A (H1N1) outbreak at the US Air Force Academy: epidemiology and viral shedding duration. Am J Prev Med 2010;38:121-6.
27. Confalonieri M, D'Agaro P, Campello C. Corticosteroids do not cause harmful increase of viral load in severe H1N1 virus infection. Intensive Care Med 2010;36: 1780-1.
28. Aviram G, Bar-Shai A, Sosna J, Rogowski O, Rosen G, Weinstein I, et al. H1N1 influenza: initial chest radiographic findings in helping predict patient outcome. Radiology 2010;255:252-9.
29. Choi SH, Kang EY, Kim JS, Kim YK. Radiologic review of an outbreak of the pandemic (H1N1) 2009 Virus In-fection at a university hospital in Seoul, Korea. JKorean Soc Radiol 2011;64:341-50.
30. Korppi M, Don M, Valent F, Calciani M. The value of clinical features in differentiating between viral, pneumococcal and atypical bacterial pneumonia in children. Acta Pediatr 2008;97:943-7. (Pubitemid 351792810)
31. World Health Organization: Human infection with new influenza A (H1N1) virus: Clinical observations from a school associated outbreak in Kobe, Japan, May 2009. Wkly Epidemiol Rec 2009;84:237-48.
32. Jain S, Kamimoto L, Bramley AM, Schmitz AM, Benoit SR, Louie J, et al. 2009 Pandemic InfluenzaA(H1N1) Virus Hospitalizations Investigation Team. Hospitalized patients with 2009 H1N1 influenza inthe United States, April-June 2009. N Engl J Med 2009; 361:1935-44.
33. Tang BM, Craig JC, Eslick GD, Seppelt I, McLean AS. Use of corticosteroids in acute lung injury and acute respiratory distress syndrome: A systemic review and meta-analysis. Crit Care Med 2009;37:1594-603.